BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31017114)

  • 1. Rapid Desensitization to Adalimumab Is Associated With Decreased Basophil Sensitivity.
    Thévenot J; Ferrier le Bouëdec MC; Buisson A; Bommelaer G; D'Incan M; Rouzaire P
    J Investig Allergol Clin Immunol; 2019 Apr; 29(2):141-143. PubMed ID: 31017114
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients.
    Bavbek S; Ataman Ş; Akıncı A; Castells M
    J Allergy Clin Immunol Pract; 2015; 3(4):629-32. PubMed ID: 25725941
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test.
    de la Varga Martínez R; Gutiérrez Fernández D; Foncubierta Fernández A; Andrés García JA; Medina Varo F
    Allergol Int; 2017 Apr; 66(2):357-359. PubMed ID: 27780662
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab desensitization protocol in a patient with a generalized urticarial reaction and angioedema following adalimumab administration.
    Gutiérrez Fernández D; Foncubierta Fernández A; Anguita Carazo JL; Fernández Meléndez S; Fernández Anguita MJ; Medina Varo F
    J Investig Allergol Clin Immunol; 2014; 24(4):273-5. PubMed ID: 25219112
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful adalimumab desensitization after generalized urticaria and rhinitis.
    Rodríguez-Jiménez B; Domínguez-Ortega J; González-Herrada C; Kindelan-Recarte C; Loribo-Bueno P; Garrido-Peño N
    J Investig Allergol Clin Immunol; 2009; 19(3):246-7. PubMed ID: 19610276
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol.
    Emmi G; Silvestri E; Cantarini L; Lopalco G; Cecchi L; Chiarini F; Farsi A
    J Dermatol; 2017 Aug; 44(8):981-982. PubMed ID: 27667671
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of drug hypersensitivity reactions.
    Romano A; Torres MJ; Castells M; Sanz ML; Blanca M
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S67-73. PubMed ID: 21354502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
    Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsuccessful Desensitization to Paclitaxel in a Patient With High Basophil Sensitivity.
    Kopač P; Koren A; Jošt M; Mangaroski D; Lainščak M; Korošec P
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):263-265. PubMed ID: 32732178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and management of drug allergy].
    Muranaka M
    Naika; 1968 Feb; 21(2):286-94. PubMed ID: 4301009
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease.
    Manzo-Silberman S; Nicaise-Roland P; Neukirch C; Tubach F; Huisse MG; Chollet-Martin S; Abergel H; Driss F; Alfaiate T; Ajzenberg N; Steg PG
    Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):77-81. PubMed ID: 27533953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 14. An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab.
    Confalonieri M; DI Meo N; Damiani G; Torregiani C; Trevisan R; Kodric M; Trevisan G
    G Ital Dermatol Venereol; 2018 Feb; 153(1):129-130. PubMed ID: 29319289
    [No Abstract]   [Full Text] [Related]  

  • 15. Desensitization to hydroxychloroquine: alternative interpretations.
    Sontheimer RD
    J Rheumatol; 2007 Feb; 34(2):253-5; discussion 255. PubMed ID: 17304648
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid desensitization of hydroxychloroquine.
    Rowane M; Schend J; Patel J; Hostoffer R
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):97-98. PubMed ID: 31606403
    [No Abstract]   [Full Text] [Related]  

  • 17. Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation.
    Bavbek S; Ataman Ş; Bankova L; Castells M
    Allergol Immunopathol (Madr); 2013; 41(3):204-6. PubMed ID: 23063342
    [No Abstract]   [Full Text] [Related]  

  • 18. Desensitization for drug allergy.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):476-81. PubMed ID: 17088655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR3 for basophil activation test: a necessary but insufficient step.
    Monneret G
    Clin Exp Allergy; 2010 Jun; 40(6):953; author reply 954. PubMed ID: 20557552
    [No Abstract]   [Full Text] [Related]  

  • 20. Immediate-Type Hypersensitivity to Atracurium: Use of the Stimulation Index as the Optimal Positivity Threshold for the Flow-Assisted Basophil Activation Test.
    Petrişor C; Gherman N; Sfichi M; Cociş M; Hagău N
    J Investig Allergol Clin Immunol; 2015; 25(5):372-3. PubMed ID: 26727770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.